{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:51:04Z","timestamp":1790049064723,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaci.2018.06.036","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T09:50:09Z","timestamp":1531907409000},"page":"1108-1118.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition"],"prefix":"10.1016","volume":"143","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Dimaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.06.036_bib1","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.1003049","article-title":"A brief history of IL-9","volume":"186","author":"Goswami","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","article-title":"Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells","volume":"33","author":"Staudt","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.06.036_bib3","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib4","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI65459","article-title":"Th9 cells promote antitumor immune responses in\u00a0vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.06.036_bib5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.06.036_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4049\/jimmunol.1102840","article-title":"STAT6-dependent regulation of Th9 development","volume":"188","author":"Goswami","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","article-title":"Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells","volume":"36","author":"Elyaman","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.06.036_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.06.036_bib11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.2925","article-title":"The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells","volume":"15","author":"Vegran","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib12","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1073\/pnas.1301138111","article-title":"Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression","volume":"111","author":"Liao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.06.036_bib13","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.4049\/jimmunol.1601624","article-title":"STAT3 Activation Impairs the Stability of Th9 Cells","volume":"198","author":"Ulrich","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ni.1659","article-title":"Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/icb.2010.53","article-title":"Regulation of human Th9 differentiation by type I interferons and IL-21","volume":"88","author":"Wong","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2018.06.036_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/cea.12787","article-title":"Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome","volume":"46","author":"Becker","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.06.036_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2018.06.036_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.06.036_bib20","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1084\/jem.20161427","article-title":"PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients","volume":"214","author":"Zhang","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.06.036_bib21","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.1200808","article-title":"IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27","volume":"189","author":"Murugaiyan","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaci.2016.08.022","article-title":"T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production","volume":"139","author":"Matsuki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib23","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.06.036_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MPH.0b013e318059c236","article-title":"Acquired factor VIII deficiency associated with a novel primary immunodeficiency suggestive of autosomal recessive hyper IgE syndrome","volume":"29","author":"Ozgur","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2018.06.036_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0091-6749(89)90471-5","article-title":"Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome","volume":"83","author":"Gorin","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib26","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/10428190400004463","article-title":"Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review","volume":"45","author":"Leonard","year":"2004","journal-title":"Leuka Lymphoma"},{"key":"10.1016\/j.jaci.2018.06.036_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/all.12416","article-title":"Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern","volume":"69","author":"Boos","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.06.036_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2015.11.024","article-title":"Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis","volume":"138","author":"Hox","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib29","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1182\/blood-2013-09-523167","article-title":"A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3","volume":"123","author":"Steward-Tharp","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2018.06.036_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri3493","article-title":"The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases","volume":"13","author":"Milner","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib31","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.4049\/jimmunol.153.9.3989","article-title":"IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma","volume":"153","author":"Schmitt","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib32","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.1501801","article-title":"STAT3 impairs STAT5 activation in the development of IL-9-secreting T cells","volume":"196","author":"Olson","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib33","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.1201496","article-title":"Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells","volume":"189","author":"Goswami","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/ni.2633","article-title":"The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation","volume":"14","author":"Yang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The development and in\u00a0vivo function of T helper 9 cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2018.06.036_bib36","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1172\/JCI69489","article-title":"Th9 cell development requires a BATF-regulated transcriptional network","volume":"123","author":"Jabeen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.06.036_bib37","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.24172","article-title":"SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL","volume":"124","author":"Barclay","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2018.06.036_bib38","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2007.14.5193","article-title":"Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma","volume":"26","author":"Thompson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2018.06.036_bib39","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1158\/1078-0432.CCR-08-2663","article-title":"Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial","volume":"15","author":"Davis","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2018.06.036_bib40","doi-asserted-by":"crossref","first-page":"e24522","DOI":"10.4161\/onci.24522","article-title":"IL-21 in cancer immunotherapy: at the right place at the right time","volume":"2","author":"Santegoets","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaci.2018.06.036_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: a double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918310017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918310017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:36Z","timestamp":1758791976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918310017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0091674918310017"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.06.036","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}